Literature DB >> 32746984

A comprehensive study on the multi-class cervical cancer diagnostic prediction on pap smear images using a fusion-based decision from ensemble deep convolutional neural network.

Elima Hussain1, Lipi B Mahanta2, Chandana Ray Das3, Ratna Kanta Talukdar3.   

Abstract

The diagnosis of cervical dysplasia, carcinoma in situ and confirmed carcinoma cases is more easily perceived by commercially available and current research-based decision support systems when the scenario of pathologists to patient ratio is small. The treatment modalities for such diagnosis rely exclusively on precise identification of dysplasia stages as followed by The Bethesda System. The classification based on The Bethesda System is a multiclass problem, which is highly relevant and vital. Reliance on image interpretation, when done manually, introduces inter-observer variability and makes the microscope observation tedious and time-consuming. Taking this into account, a computer-assisted screening system built on deep learning can significantly assist pathologists to screen with correct predictions at a faster rate. The current study explores six different deep convolutional neural networks- Alexnet, Vggnet (vgg-16 and vgg-19), Resnet (resnet-50 and resnet-101) and Googlenet architectures for multi-class (four-class) diagnosis of cervical pre-cancerous as well as cancer lesions and incorporates their relative assessment. The study highlights the addition of an ensemble classifier with three of the best deep learning models for yielding a high accuracy multi-class classification. All six deep models including ensemble classifier were trained and validated on a hospital-based pap smear dataset collected through both conventional and liquid-based cytology methods along with the benchmark Herlev dataset.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical dysplasia; Classification; Convolutional neural network; Deep learning; Pap smear

Mesh:

Year:  2020        PMID: 32746984     DOI: 10.1016/j.tice.2020.101347

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  6 in total

1.  Five-Class Classification of Cervical Pap Smear Images: A Study of CNN-Error-Correcting SVM Models.

Authors:  Audrey K C Huong; Kim Gaik Tay; Xavier T I Ngu
Journal:  Healthc Inform Res       Date:  2021-10-31

Review 2.  Artificial Intelligence in Cervical Cancer Screening and Diagnosis.

Authors:  Xin Hou; Guangyang Shen; Liqiang Zhou; Yinuo Li; Tian Wang; Xiangyi Ma
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

Review 3.  Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment.

Authors:  Zofia Łapińska; Urszula Szwedowicz; Anna Choromańska; Jolanta Saczko
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

4.  An Ensemble-Based Deep Convolutional Neural Network for Computer-Aided Polyps Identification From Colonoscopy.

Authors:  Pallabi Sharma; Bunil Kumar Balabantaray; Kangkana Bora; Saurav Mallik; Kunio Kasugai; Zhongming Zhao
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

5.  A Comparative Analysis of Deep Learning Models for Automated Cross-Preparation Diagnosis of Multi-Cell Liquid Pap Smear Images.

Authors:  Yasmin Karasu Benyes; E Celeste Welch; Abhinav Singhal; Joyce Ou; Anubhav Tripathi
Journal:  Diagnostics (Basel)       Date:  2022-07-29

6.  Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears.

Authors:  Xiaohui Zhu; Xiaoming Li; Kokhaur Ong; Wenli Zhang; Wencai Li; Longjie Li; David Young; Yongjian Su; Bin Shang; Linggan Peng; Wei Xiong; Yunke Liu; Wenting Liao; Jingjing Xu; Feifei Wang; Qing Liao; Shengnan Li; Minmin Liao; Yu Li; Linshang Rao; Jinquan Lin; Jianyuan Shi; Zejun You; Wenlong Zhong; Xinrong Liang; Hao Han; Yan Zhang; Na Tang; Aixia Hu; Hongyi Gao; Zhiqiang Cheng; Li Liang; Weimiao Yu; Yanqing Ding
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.